Vectus Biosystems: Could this drug eventually prevent thousands of deaths?
Listen to ASX-listed Vectus Biosystems CEO Karen Duggan talk to Matt Birney on the Bulls N’ Bears Report about Vectus’ rapidly developing treatment for a condition that is a factor in up to 40 per cent of all deaths.

Augustus Minerals: Brand new gold discovery – and it’s in granite!
03:07

49 Metals: A $10m gold/silver IPO, old workings everywhere and a big IP anomaly lurking
03:00

Hastings Technology Metals: A rare earths game changer – a mothballed plant that has never fired a shot
02:58